Internal Medicine · Charleston, SC
NPI
1114313335
Since 2015
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
171 Ashley Ave
Charleston, SC, 29425
Phone (843) 792-3167
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
915 services
Medicare patients, 2024
437
Average age 72
Drug cost, 2024
$4.3M
1,207 prescriptions
Company payments, 2025
$1,516
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christina M Mingora was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 106 times for 99 patients. In total Christina M Mingora billed 915 services in 22 codes, and Medicare paid $44K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-20.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 106 | 99 | $12.12 | $1,284 |
| 94010 Pulmonary Function Testing | Facility | 104 | 101 | $6.00 | $624 |
| 99215 Office E&M - Established | Facility | 95 | 86 | $94.05 | $8,934 |
| 94010 Pulmonary Function Testing | Office | 90 | 89 | $8.71 | $784 |
| 99291 Critical Care E&M | Facility | 78 | 29 | $159.08 | $12K |
| 94729 Pulmonary Function Testing | Office | 74 | 73 | $14.66 | $1,085 |
| 99214 Office E&M - Established | Facility | 68 | 64 | $67.22 | $4,571 |
| 94729 Pulmonary Function Testing | Facility | 58 | 58 | $6.49 | $377 |
| 99205 Office E&M - New | Facility | 41 | 41 | $126.06 | $5,169 |
| 99232 Hospital E&M - Subsequent | Facility | 32 | 12 | $56.32 | $1,802 |
| 94618 Pulmonary Function Testing | Facility | 28 | 28 | $16.52 | $463 |
| 94618 Pulmonary Function Testing | Office | 23 | 22 | $19.96 | $459 |
| 99233 Hospital E&M - Subsequent | Facility | 21 | 20 | $88.59 | $1,860 |
| 94726 Pulmonary Function Testing | Office | 17 | 16 | $24.36 | $414 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 16 | 16 | $12.37 | $198 |
By year: 2022 $55K for 1,055 services; 2023 $43K for 829 services; 2024 $44K for 915 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christina M Mingora prescribed most often to Medicare patients was Azithromycin, with 124 prescriptions and refills. In total Christina M Mingora wrote 1,207 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azithromycin Generic | 124 | 178 | 29 | $2,003 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 92 | 107 | 30 | $3,236 |
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 88 | 93 | 16 | $2.2M |
| Nuzyra Omadacycline Tosylate | 67 | 76 | 13 | $785K |
| Ethambutol Hcl Generic | 60 | 74 | 20 | $2,827 |
| Arikayce Amikacin Liposomal/Neb.Accessr | 43 | 45 | 12 | $593K |
| Amikacin Sulfate Generic | 41 | 45 | 11 | $5,046 |
| Omeprazole Generic | 36 | 68 | 15 | $369 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 34 | 62 | 11 | $39K |
| Montelukast Sodium Generic | 33 | 53 | Under 11 | $382 |
| Imipenem-Cilastatin Sodium Imipenem/Cilastatin Sodium | 30 | 30 | Under 11 | $6,733 |
| Creon Lipase/Protease/Amylase | 29 | 31 | Under 11 | $209K |
| Symbicort Budesonide/Formoterol Fumarate | 28 | 41 | Under 11 | $7,964 |
| Cefepime Hcl Generic | 26 | 26 | Under 11 | $6,308 |
| Dupixent Pen Dupilumab | 24 | 29 | Under 11 | $108K |
Brand drugs: 553 claims; generic drugs: 638 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christina M Mingora $1,516 ($122 in general payments such as food, travel and fees and $1,395 for research) from 2 companies. The largest payer was GlaxoSmithKline, LLC. with $1,395.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 11 | $1,395 |
| Viatris Specialty LLC | 1 | $122 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.